Results 231 to 240 of about 8,178,562 (344)

How Do Artificial Intelligence Applications in Breast Cancer Impact Health Equity, Particularly in Diagnosis, Treatment, and Outcomes of Diverse Groups: A Critical Literature Review (Preprint)

Kethakee Madhavika Andaraweera, R. Chauhan, Arpana Verma   +2 more
openalex   +1 more source

Workshop to Identify Critical Windows of Exposure for Children's Health: Reproductive Health in Children and Adolescents Work Group Summary

, 2000
Grace K. LeMasters, Sally D. Perreault, Barbara F. Hales, Maureen Hatch, Anne N. Hirshfield, Claude L. Hughes, Gary L. Kimmel, James C. Lamb, Jon L. Pryor, Carol Rubin, Jennifer Seed   +10 more
openalex   +1 more source

Combining antibody conjugates with cytotoxic and immune‐stimulating payloads maximizes anti‐cancer activity

Molecular Oncology, EarlyView.
Methods to improve antibody–drug conjugate (ADC) treatment durability in cancer therapy are needed. We utilized ADCs and immune‐stimulating antibody conjugates (ISACs), which are made from two non‐competitive antibodies, to enhance the entry of toxic payloads into cancer cells and deliver immunostimulatory agents into immune cells.
Tiexin Wang, Dong Jun Koo, Peter M. Tessier, Greg M. Thurber   +3 more
wiley   +1 more source

Identifying social prescribing core outcomes using a Delphi approach: findings and future directions. [PDF]

Health Promot Chronic Dis Prev Can
Ashe MC, Chudyk AM, Lin M, Iverson T, Singh Nijjar G, Mortenson WB, Pauly T, Petrella R, Rush KL, Symes B, Tsuei S, Mulligan K.   +11 more
europepmc   +1 more source

ONE-GROUP TWO-DIMENSIONAL CRITICAL SIZE PREDICTION SUBROUTINE.

, 1968
D. Mathews
openalex   +2 more sources

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

Publisher Correction: Volatile sedation in critically ill adults undergoing mechanical ventilation: not all sedatives are equivalent, in sustainability! [PDF]

Crit Care
Boissier F, Massart N, Frapard T, Lecronier M, Demoule A, Grimaldi D, REAGIR group, Kalmar AF, Zieleskiewicz L.   +8 more
europepmc   +1 more source

Tumor mutational burden as a determinant of metastatic dissemination patterns

Molecular Oncology, EarlyView.
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal, Andrea Moreno‐Manuel, Miguel Salvadó‐Pertierra, Cristina Santos‐Vivas, Rebeca Sanz‐Pamplona   +4 more
wiley   +1 more source

Device-measured capillary refill time identifies critically ill cases in the emergency department. [PDF]

Sci Rep
Miwa Y, Karasawa S, Shimazui T, Oami T, Miyazawa C, Shinozaki M, Nakaguchi T, Nakada TA.   +7 more
europepmc   +1 more source

Targeting p38α in cancer: challenges, opportunities, and emerging strategies

Molecular Oncology, EarlyView.
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley   +1 more source